Blood Pressure Monitoring最新文献

{"title":"Effect of nifedipine combined with magnesium sulfate on gestational hypertension and its impact on blood lipids.","authors":"Hong Cheng, Shaoning Xing, Aizhen Fu, Hengjing Li","doi":"10.1097/MBP.0000000000000780","DOIUrl":"10.1097/MBP.0000000000000780","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the efficacy of nifedipine combined with magnesium sulfate in pregnant women with gestational hypertension (GH) and its influence on blood lipid levels.</p><p><strong>Methods: </strong>Seventy pregnant women with GH were randomly assigned to either a control group (labetalol plus magnesium sulfate) or an observation group (nifedipine extended-release tablets plus magnesium sulfate) ( n  = 35). Both groups were treated for 7 days. Posttreatment, changes in blood pressure (SBP and DBP), hemorheological parameters [whole blood high-shear viscosity, low-shear viscosity, plasma viscosity (PV)], blood lipid levels [high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and total cholesterol (TC)], adverse reactions, and pregnancy outcomes were assessed.</p><p><strong>Results: </strong>Posttreatment, both groups showed significant reductions in SBP and DBP, with greater decreases in the observation group ( P  < 0.05). After 7 days of treatment, whole blood high-shear viscosity, low-shear viscosity, and PV decreased in both groups, with lower values for these in the observation group ( P  < 0.05). Lipid profiles improved in both groups, with the observation group showing higher HDL-C and lower LDL-C, TG, and TC ( P  < 0.05). The observation group had a higher overall efficacy rate (94.29 vs. 77.14%, P  < 0.05) and fewer adverse pregnancy outcomes (8.57% vs. 28.57%, P  < 0.05), while the incidence of adverse reactions was comparable between groups.</p><p><strong>Conclusion: </strong>Nifedipine combined with magnesium sulfate is more effective in managing GH. This regimen better improves blood pressure, hemorheological parameters, lipid profiles, and pregnancy outcomes, with good safety.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"29-34"},"PeriodicalIF":1.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the automated oscillometric upper-arm cuff home blood pressure monitor Microlife BP3KV1-5X (BP B6 Connect) in a general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard (ISO 81060-2:2018).","authors":"Ariadni Menti, Vasileios Ntousopoulos, Petroula Lempidaki, Konstantina-Rozalia Bakalakou, Aikaterini Komnianou, Dimitrios Mariglis, Evangelia Ntaskagianni, Anastasios Kollias, George S Stergiou","doi":"10.1097/MBP.0000000000000771","DOIUrl":"10.1097/MBP.0000000000000771","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the accuracy of the automated oscillometric upper-arm cuff blood pressure (BP) monitor Microlife BP3KV1-5X (BP B6 Connect) for home use in a general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018) and its amendments (1:2020 and 2:2024).</p><p><strong>Methods: </strong>Participants were recruited to fulfill the age, sex, BP, and arm distribution criteria of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) and its amendments (1:2020 and 2:2024) in a general population using the same arm sequential measurement method. A single wide-range cuff of the test device was used for arm circumference 22-42 cm.</p><p><strong>Results: </strong>One-hundred and twenty individuals were recruited and 85 were analyzed [mean age: 55.8 ± 15.6 (SD) years, 41 men, arm circumference 31.9 ± 5.1 cm, range: 23-41.8 cm]. For validation criterion 1, the mean difference ± SD between the test device and reference BP readings ( N  = 255) was -0.8 ± 6.8/-2.3 ± 4.9 mmHg (systolic/diastolic; threshold ≤5 ± 8 mmHg). For criterion 2, the SD of the averaged BP differences between the test device and reference BP per individual ( N  = 85) was 5.99/4.35 mmHg (systolic/diastolic; threshold ≤ 6.89/6.55 mmHg).</p><p><strong>Conclusion: </strong>The automated oscillometric home BP monitor Microlife BP3KV1-5X (B6 Connect) fulfilled all the requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) and its amendments (1:2020 and 2:2024) in a general population and can be recommended for home use.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"35-38"},"PeriodicalIF":1.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145032706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the DBP-6279B arm-type fully automatic digital blood pressure monitor in pregnancy according to the ISO 81060-2:2018/AMD 1:2020 protocol.","authors":"Rong Yang, Fen Li","doi":"10.1097/MBP.0000000000000779","DOIUrl":"10.1097/MBP.0000000000000779","url":null,"abstract":"<p><p>To evaluate the accuracy of the DBP-6279B arm-type fully automatic digital blood pressure monitor in pregnant populations according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard (ISO 81060-2:2018/AMD 1:2020) and the Recognized Consensus Standards published by the Food and Drug Administration (FR Recognized List No.056, FR Recognized No. 3-166), a total of 115 pregnant women were enrolled in this clinical trial. One participant was excluded because it met the data exclusion criteria. The arm circumference and subgroup distributions of the subjects met the requirements of the protocol. According to criterion 1, the mean difference of systolic blood pressure between the test device and the reference device was ‑0.89 mmHg, with a SD of 5.60 mmHg. The mean difference of diastolic blood pressure was ‑0.17 mmHg, with a SD of 4.65 mmHg. The mean difference in both systolic and diastolic blood pressure was less than 5.0 mmHg, and the SD was less than 8.0 mmHg. Additional analyses were also conducted in accordance with criterion 2 and the results met the requirements, too. Therefore, it is recommended for pregnant populations in home and clinical use.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"49-52"},"PeriodicalIF":1.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12736392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145443833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges in validation studies of blood pressure measurement devices.","authors":"Hakuo Takahashi, Kei Asayama","doi":"10.1097/MBP.0000000000000777","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000777","url":null,"abstract":"<p><p>Accurate blood pressure (BP) measurement is essential for effective health management. To ensure this, international standards for the validation of BP monitors have been established and revised over time, with ISO 81060-2:2018 being the most recent. While many studies have been published evaluating the accuracy of BP monitors based on this standard, we identified concerns regarding the reliability of some reported results and therefore conducted a comprehensive literature review. Using ISO 81060-2:2018 as the validation framework, we extracted relevant studies from PubMed and collected the SD values for criterion 1 to compare and analyze the reported measurement accuracy. While most SD values ranged from 5 to 8%, we identified six studies reporting values below 4%. On the basis of our experience, such low variability is highly implausible and raises questions about the credibility of these findings. Reports claiming exceptionally high measurement accuracy with unusually low SD values may lead to misconceptions and could potentially be misused for marketing purposes. Therefore, validation studies must be conducted in strict adherence to medical ethics. In addition, there is a need to raise awareness that the current international standards for BP monitor validation require further refinement.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"31 1","pages":"1-5"},"PeriodicalIF":1.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145854113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validating the accuracy of Omron HBP-1320 electronic blood pressure monitor in pediatric and adult populations according to Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018/Amd 1:2020).","authors":"Li Qin, Jie Dong, Hong Jiang, Ya Sun, Jiayi Zhai, Yaya Xue, Ming Liu, Fulai Shen, Yicheng Qiu, Jianhui Xie, Wuquan Huang","doi":"10.1097/MBP.0000000000000774","DOIUrl":"https://doi.org/10.1097/MBP.0000000000000774","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the accuracy of the Omron HBP-1320 electronic blood pressure (BP) monitor for ambulatory BP measurement in both pediatric and adult populations according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) (ISO 81060-2:2018/Amd 1:2020) protocol.</p><p><strong>Methods: </strong>Subjects who met age, gender, BP, and cuff distribution criteria specified by the AAMI/ESH/ISO (ISO 81060-2:2018/Amd1:2020) protocol were recruited for this study. BP measurements were performed using the same-arm sequential measurement method. The test device was equipped with cuffs suitable for arm circumferences ranging from 12.0 to 42.0 cm.</p><p><strong>Results: </strong>A total of 87 participants were initially recruited, with 85 (35 children and 50 adults) included in the final analysis after excluding two participants. The mean age of all participants was 38.1 ± 28.98 years, with children averaging 6.7 ± 2.23 years and adults 60.1 ± 15.39 years. For validation criterion 1, the mean ± SD of differences between the test device and reference BP measurements was 2.3 ± 5.47 mmHg for SBP and 1.3 ± 5.65 mmHg for DBP. Both mean differences were ≤5 mmHg, and SDs ≤ 8 mmHg, meeting the criterion. For validation criterion 2, the mean differences were 2.3 ± 3.93 mmHg for SBP and 1.3 ± 5.13 mmHg for DBP, satisfying the thresholds of ≤6.55 mmHg for SBP and ≤6.82 mmHg for DBP.</p><p><strong>Conclusion: </strong>The Omron HBP-1320 electronic BP monitor meets the requirements of the AAMI/ESH/ISO (ISO 81060-2:2018/Amd 1:2020) validation standard for adults and children.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of phenotypic age acceleration with the risk of all-cause and cardiovascular disease-related mortality in patients with hypertension.","authors":"Qiao Yu, Baoling Shang, Haijiao Sun, Wei Jiang, Qian Cao, Xu Zou","doi":"10.1097/MBP.0000000000000766","DOIUrl":"10.1097/MBP.0000000000000766","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the associations between phenotypic age acceleration (PhenoAgeAccel) and all-cause/cardiovascular disease (CVD)-related mortality in hypertensive patients.</p><p><strong>Methods: </strong>We analyzed data from 14 352 hypertensive adults (≥20 years) in the National Health and Nutrition Examination Survey 1999-2010. PhenoAge was calculated using chronological age and nine biomarkers (albumin, creatinine, glucose, C-reactive protein, lymphocyte%, mean cell volume, red blood cell distribution width, alkaline phosphatase, and white blood cell count). PhenoAgeAccel was derived as residuals from linear regression of PhenoAge on chronological age. Participants were stratified by PhenoAge [<46.6792 (792-64.774 (T1-T2), ≥64.774 (≥T2)] and PhenoAgeAccel [<-4.3382 (382-0.9896 (T1-T2), ≥0.9896 (≥T2)] tertiles. Cox proportional hazards models assessed mortality risks.</p><p><strong>Results: </strong>Increased all-cause mortality was observed in hypertensive patients with PhenoAge in T1-T2 group [hazards ratio = 4.38, 95% confidence interval (CI): 3.79-5.06] and greater than or equal to T2 (hazards ratio = 14.22, 95% CI: 12.32-16.43). Significant association between PhenoAgeAccel greater than or equal to T2 and increased risk of all-cause mortality in hypertensive patients (hazards ratio = 1.41, 95% CI: 1.29-1.55) was identified. PhenoAge of T1-T2 (hazards ratio = 5.15, 95% CI: 3.86-6.86) and greater than or equal to T2 (hazards ratio = 20.20, 95% CI: 14.98-27.26) were related to increased CVD-related mortality in hypertensive patients. Increased risk of CVD-related mortality was identified in hypertensive patients with PhenoAgeAccel greater than or equal to T2 (hazards ratio = 1.35, 95% CI: 1.17-1.56).</p><p><strong>Conclusion: </strong>Elevated PhenoAge and PhenoAgeAccel significantly predict higher all-cause and CVD mortality in hypertension, supporting clinical risk stratification.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"222-233"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144783417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the Omron J7136 and HEM-7361T blood pressure monitors according to the International Organization for Standardization protocol (ISO 81060-2:2018 + Amd.1:2020).","authors":"Yi Zhou, Xin-Yu Wang, Yi Zhou, Yan Li, Ji-Guang Wang","doi":"10.1097/MBP.0000000000000756","DOIUrl":"10.1097/MBP.0000000000000756","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the accuracy of OMRON J7136 and HEM-7361T oscillometric blood pressure (BP) monitors in the general population according to the International Organization for Standardization (ISO) 81060-2:2018 and amendment (Amd) 1:2020 standard.</p><p><strong>Method: </strong>Subjects were recruited to fulfill the age, gender, BP, and cuff distributions of the ISO Universal Standard in the general population using the same arm sequential BP measurement method. Three cuffs of the OMRON J7136 were used for arm circumference 17-22 cm (small), 22-32 cm (medium), and 32-42 cm (large). A single cuff 17-36 cm was used on the OMRON HEM-7361T.</p><p><strong>Results: </strong>The mean ± SD of the differences between the OMRON J7136 and reference BP readings was -2.14 ± 6.45/-1.43 ± 5.88 mmHg (systolic/diastolic) for criterion 1. The SD of the average BP differences between the OMRON J7136 and reference BP per subject was 5.49/5.36 mmHg (systolic/diastolic) for criterion 2. For the study on the OMRON HEM-7361T, the corresponding values were -2.56 ± 6.35/-3.18 ± 5.67 mmHg (systolic/diastolic) for criterion 1 and 5.33/5.32 mmHg (systolic/diastolic) for criterion 2.</p><p><strong>Conclusion: </strong>The OMRON J7136 and HEM-7361T BP monitors both fulfilled the requirements of the ISO Universal Standard (ISO 81060-2:2018/AMD 1:2020) in the general population and can be recommended for self-measurement in adults.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"236-242"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144172420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The possible role of disrupted circadian blood pressure rhythm and excess early morning blood pressure surge in the prediction of future hypertension and hypertension-related target organ damage in patients with a high normal blood pressure profile.","authors":"Cemal Köseoğlu, Can Ramazan Öncel, Ali Çoner","doi":"10.1097/MBP.0000000000000761","DOIUrl":"10.1097/MBP.0000000000000761","url":null,"abstract":"","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"30 5","pages":"243-244"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144941397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antihypertensive treatment of a patient with normal blood pressure: case report and call for paying attention.","authors":"Hasan Atmaca, Mustafa Kemal Erol, Ertan Yetkin","doi":"10.1097/MBP.0000000000000758","DOIUrl":"10.1097/MBP.0000000000000758","url":null,"abstract":"<p><p>The current 2024 European Society of Cardiology (ESC) guideline for the management of elevated blood pressure and hypertension defines blood pressure less than 115/65 mmHg by ambulatory blood pressure monitoring (ABPM) as nonelevated, blood pressures in-between 115-129 and 65-79 mmHg as elevated blood pressure, and hypertension as ≥130/80 mmHg. There, might be patients seeking medical attention for the symptoms, apparently nonspecific but suggestive of hypertension with optimal, or not elevated, or elevated blood pressure values. A female patient with complaints of headache and dizziness lasting for 2 months has been evaluated in cardiology outpatient clinic and assessed by ABPM. It has been told that she had previously blood pressure of 90-100/50-60 mmHg and was suffering from headache when systolic blood pressure exceeds 110 mmHg. Her 24-h ABPM revealed systolic and diastolic blood pressure as 106/63 mmHg showing nighttime decrease compared with daytime pressures (98/59 mmHg and 108/68 mmHg, respectively). Thereafter, she was instructed to keep continuing the life-style modification and given to beta-blocker (bisoprolol 5 mg) as an antihypertensive treatment. At the end of the 2 weeks of follow-up period, she was headache-free and was feeling comfortable and well with a mean home blood pressure of 98/56 mmHg. We have presented prosperous antihypertensive treatment of a female patient suffering from headache and dizziness with a numerically normal or nonelevated blood pressure. In the presence of symptoms and having not elevated or elevated blood pressure levels, patients' history on previous measure of blood pressure might facilitate our decision-making process.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":"234-235"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to: 'The possible role of disrupted circadian blood pressure rhythm and excess early morning blood pressure surge in the prediction of future hypertension and hypertension-related target organ damage in patients with a high normal blood pressure profile'.","authors":"Theodoros Kalos, Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Tsioufis","doi":"10.1097/MBP.0000000000000763","DOIUrl":"10.1097/MBP.0000000000000763","url":null,"abstract":"","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":"30 5","pages":"245"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144941450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}